<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36787922</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2022-000874</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine the possible predictive value of self-efficacy on health-related quality of life (HRQoL) in patients with SLE.</AbstractText><AbstractText Label="METHODS">Patients with SLE from the Almenara Lupus Cohort were included. Self-efficacy was ascertained with the six domains from the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing chronic conditions. For PROMIS domains, a score of 50 is the average for a clinical population (people with a chronic condition), a higher score indicates that the respondent has greater self-efficacy. HRQoL was ascertained with the physical and mental component summary (PCS and MCS) measures of the Short-Form 36 (SF-36). Generalised estimating equations were performed, using as outcome the PCS or MCS in the subsequent visit, and the self-efficacy domain in the previous visit; multivariable models were adjusted for possible confounders. The confounders were measured in the same visit as the self-efficacy domain.</AbstractText><AbstractText Label="RESULTS">Two-hundred and nine patients for a total of 564 visits were included; 194 (92.8%) patients were women and mean age at diagnosis was 36.4 (14.0) years. In the multivariable models, a better PCS was predicted by a better self-efficacy for managing symptoms, managing medications and treatments and managing social interactions and general self-efficacy; a better MCS was predicted by a better self-efficacy for managing daily activities, managing symptoms, managing medications and treatments and managing social interactions.</AbstractText><AbstractText Label="CONCLUSION">A better self-efficacy is predictive of subsequent better HRQoL, even after adjustment for possible confounders. These results should encourage clinicians to develop strategies to improve self-efficacy in patients with SLE.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ugarte-Gil</LastName><ForeName>Manuel Francisco</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0003-1728-1999</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru mugarte@cientifica.edu.pe.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo Peruano de Estudio de Enfermedades Autoinmunes Sist&#xe9;micas, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamboa-Cardenas</LastName><ForeName>Rocio Violeta</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo Peruano de Estudio de Enfermedades Autoinmunes Sist&#xe9;micas, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Re&#xe1;tegui-Sokolova</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3421-2717</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n para la Generaci&#xf3;n y S&#xed;ntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimentel-Quiroz</LastName><ForeName>Victor Rom&#xe1;n</ForeName><Initials>VR</Initials><Identifier Source="ORCID">0000-0002-3638-7054</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo Peruano de Estudio de Enfermedades Autoinmunes Sist&#xe9;micas, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina</LastName><ForeName>Mariela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elera-Fitzcarrald</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Ica, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Bellido</LastName><ForeName>Zoila</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor-Asurza</LastName><ForeName>Cesar Augusto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perich-Campos</LastName><ForeName>Risto Alfredo</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSaalud, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Graciela S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Max E. Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020377" MajorTopicYN="N">Self Efficacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword><Keyword MajorTopicYN="N">outcome assessment, health care</Keyword><Keyword MajorTopicYN="N">quality of lIfe</Keyword></KeywordList><CoiStatement>Competing interests: MFU-G has grant support from Janssen and Pfizer and he has been speaker for GSK; RVG-C has grant support from Pfizer; CR-S and VRP-Q have grant support from Janssen. All other authors declare to have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>20</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36787922</ArticleId><ArticleId IdType="pmc">PMC9930544</ArticleId><ArticleId IdType="doi">10.1136/lupus-2022-000874</ArticleId><ArticleId IdType="pii">10/1/e000874</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clark NM, Dodge JA. Exploring self-efficacy as a predictor of disease management. Health Educ Behav 1999;26:72&#x2013;89. 10.1177/109019819902600107</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/109019819902600107</ArticleId><ArticleId IdType="pubmed">9952053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood P, Romero S, Velozo C, et al. . Defining self-efficacy for managing chronic conditions and identifying priority sub-domains: a web-based delphi technique. Arch Phys Med Rehabil 2015;96:e43. 10.1016/j.apmr.2015.08.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2015.08.140</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Riley W, Stone A, et al. . The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010;63:1179&#x2013;94. 10.1016/j.jclinepi.2010.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.011</ArticleId><ArticleId IdType="pmc">PMC2965562</ArticleId><ArticleId IdType="pubmed">20685078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber-Baldini AL, Velozo C, Romero S, et al. . Validation of the PROMIS&#xae; measures of self-efficacy for managing chronic conditions [Quality of life research&#x202f;: an international journal of quality of life aspects of treatment, care and rehabilitation]. Qual Life Res 2017;26:1915&#x2013;24. 10.1007/s11136-017-1527-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-017-1527-3</ArticleId><ArticleId IdType="pmc">PMC5479750</ArticleId><ArticleId IdType="pubmed">28239781</ArticleId></ArticleIdList></Reference><Reference><Citation>Salsman JM, Schalet BD, Merluzzi TV, et al. . Calibration and initial validation of a general self-efficacy item bank and short form for the NIH PROMIS&#xae; [Quality of life research&#x202f;: an international journal of quality of life aspects of treatment, care and rehabilitation]. Qual Life Res 2019;28:2513&#x2013;23. 10.1007/s11136-019-02198-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-019-02198-6</ArticleId><ArticleId IdType="pmc">PMC6698413</ArticleId><ArticleId IdType="pubmed">31140041</ArticleId></ArticleIdList></Reference><Reference><Citation>Elera-Fitzcarrald C, Fuentes A, Gonz&#xe1;lez LA, et al. . Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions. Expert Rev Clin Immunol 2018;14:915&#x2013;31. 10.1080/1744666X.2018.1529566</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1529566</ArticleId><ArticleId IdType="pubmed">30266076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, Liu CY, Huang CC, et al. . Frailty and quality of life among older adults in communities: the mediation effects of daily physical activity and healthy life self-efficacy. Geriatrics (Basel) 2022;7:125. 10.3390/geriatrics7060125</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics7060125</ArticleId><ArticleId IdType="pmc">PMC9680389</ArticleId><ArticleId IdType="pubmed">36412614</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman LM, Velozo C, Romero S, et al. . Comparative study of PROMIS&#x24e1; self-efficacy for managing chronic conditions across chronic neurologic disorders [Quality of life research&#x202f;: an international journal of quality of life aspects of treatment, care and rehabilitation]. Qual Life Res 2019;28:1893&#x2013;901. 10.1007/s11136-019-02164-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-019-02164-2</ArticleId><ArticleId IdType="pmc">PMC7071345</ArticleId><ArticleId IdType="pubmed">30915674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte-Gil MF, Gamboa-C&#xe1;rdenas RV, Zevallos F, et al. . High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus 2014;23:969&#x2013;74. 10.1177/0961203314531083</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314531083</ArticleId><ArticleId IdType="pubmed">24718588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the american college of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Iba&#xf1;ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D, Ginzler E, Goldsmith C, et al. . The development and initial validation of the systemic lupus international collaborating clinics/american College of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363&#x2013;9. 10.1002/art.1780390303</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780390303</ArticleId><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Sherbourne CD. The mos 36-ltem short-form health survey (SF-36). Medical Care 1992;30:473&#x2013;83. 10.1097/00005650-199206000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Process of translation and adaptation of instruments. Available: https://www.google.com.pe/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=&amp;cad=rja&amp;uact=8&amp;ved=2ahUKEwjKmZfOy9H8AhWQKLkGHRd0AzcQFnoECBMQAw&amp;url=https%3A%2F%2Fwww.mhinnovation.net%2Fsites%2Fdefault%2Ffiles%2Ffiles%2FWHO%2520Guidelines%2520on%2520Translation%2520and [Accessed 18 Jan 2023].</Citation></Reference><Reference><Citation>Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res 1991;26:499&#x2013;510. 10.1207/s15327906mbr2603_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327906mbr2603_7</ArticleId><ArticleId IdType="pubmed">26776715</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Moghadam-Kia S, Taylor L, et al. . Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 2011;64:849&#x2013;58. 10.1016/j.jaad.2010.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2010.02.008</ArticleId><ArticleId IdType="pmc">PMC3079065</ArticleId><ArticleId IdType="pubmed">21397983</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly M, Toloza S, Goker B, et al. . Disease-specific quality of life in patients with lupus nephritis. Lupus 2018;27:257&#x2013;64. 10.1177/0961203317717082</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317717082</ArticleId><ArticleId IdType="pubmed">28728507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro M, Hashizume H, Ikeda T, et al. . Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan. Lupus 2014;23:93&#x2013;101. 10.1177/0961203313509293</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313509293</ArticleId><ArticleId IdType="pubmed">24197553</ArticleId></ArticleIdList></Reference><Reference><Citation>Drenkard C, Easley K, Bao G, et al. . Cross-sectional study of the effects of self-efficacy on fatigue and pain interference in black women with systemic lupus erythematosus: the role of depression, age and education. Lupus Sci Med 2022;9:e000566. 10.1136/lupus-2021-000566</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000566</ArticleId><ArticleId IdType="pmc">PMC8845307</ArticleId><ArticleId IdType="pubmed">35149578</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni D, Cicognani E, Prati G. Health-related quality of life in systemic lupus erythematosus: a longitudinal study on the impact of problematic support and self-efficacy. Lupus 2017;26:125&#x2013;31. 10.1177/0961203316646459</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316646459</ArticleId><ArticleId IdType="pubmed">27125289</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams EM, Penfield M, Kamen D, et al. . An intervention to reduce psychosocial and biological indicators of stress in African American lupus patients: the balancing lupus experiences with stress strategies study. Open J Prev Med 2014;4:22&#x2013;31. 10.4236/ojpm.2014.41005</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ojpm.2014.41005</ArticleId><ArticleId IdType="pmc">PMC4079044</ArticleId><ArticleId IdType="pubmed">24999444</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams EM, Hyer JM, Viswanathan R, et al. . Peer-to-peer mentoring for African American women with lupus: a feasibility pilot. Arthritis Care Res (Hoboken) 2018;70:908&#x2013;17. 10.1002/acr.23412</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23412</ArticleId><ArticleId IdType="pmc">PMC5962359</ArticleId><ArticleId IdType="pubmed">29161471</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Riordan R, Doran M, Connolly D. Fatigue and activity management education for individuals with systemic lupus erythematosus. Occup Ther Int 2017;2017:4530104. 10.1155/2017/4530104</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/4530104</ArticleId><ArticleId IdType="pmc">PMC5612683</ArticleId><ArticleId IdType="pubmed">29097965</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortin PR, Neville C, Julien A-S, et al. . Measuring the impact of mylupusguide in canada: results of a randomized controlled study. Arthritis Care Res (Hoboken) 2022;28. 10.1002/acr.24871</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24871</ArticleId><ArticleId IdType="pubmed">35225436</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Calderon J, Meeus M, Struyf F, et al. . The role of self-efficacy in pain intensity, function, psychological factors, health behaviors, and quality of life in people with rheumatoid arthritis: a systematic review. Physiother Theory Pract 2020;36:21&#x2013;37. 10.1080/09593985.2018.1482512</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09593985.2018.1482512</ArticleId><ArticleId IdType="pubmed">29873569</ArticleId></ArticleIdList></Reference><Reference><Citation>Selzler AM, Habash R, Robson L, et al. . Self-efficacy and health-related quality of life in chronic obstructive pulmonary disease: a meta-analysis. Patient Educ Couns 2020;103:682&#x2013;92. 10.1016/j.pec.2019.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2019.12.003</ArticleId><ArticleId IdType="pubmed">31859120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi S, Gholamnezhad Z, Kasraie N, et al. . The effects of self-efficacy and physical activity improving methods on the quality of life in patients with diabetes: a systematic review. J Diabetes Res 2022;2022:2884933. 10.1155/2022/2884933</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2884933</ArticleId><ArticleId IdType="pmc">PMC9348907</ArticleId><ArticleId IdType="pubmed">35936392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>